BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Latest Press Release
BONESUPPORT’s FDA notification: Approval on DeNovo pathway for CERAMENT G will require additional data and clarifications
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
BONESUPPORT HOLDING AB (publ) – Publishes Full year report 2020